Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

48.19 +1.12 (+2.38%)
Official Closing Price Updated: 7:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,787,447
Open 48.27
Bid (Size) 48.25 (4)
Ask (Size) 48.47 (1)
Prev. Close 47.07
Today's Range 47.55 - 49.03
52wk Range 46.90 - 139.74
Shares Outstanding N/A
Dividend Yield 4.56%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity?
Competition from all sides is causing Novo Nordisk to revise its expectations for 2025. 
Via The Motley Fool
Benzinga Bulls And Bears: Celestica, Carvana, Novo Nordisk — And Fed Holds Rates Despite Trump Pressure
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Topics Economy Government

Performance

YTD
-44.9%
-44.9%
1 Month
-31.0%
-31.0%
3 Month
-30.4%
-30.4%
6 Month
-42.9%
-42.9%
1 Year
-63.6%
-63.6%

More News

Read More
Why Eli Lilly Stock Topped the Market Today
Via The Motley Fool
Topics Government
Why Novo Nordisk Stock Bumped Higher on Friday
Via The Motley Fool
Topics Government
Will Hims & Hers Fall Along With Novo Nordisk?
Via MarketBeat
Why Novo Nordisk Stock Imploded This Week
Via The Motley Fool
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
From Faruqi & Faruqi LLP
Via GlobeNewswire
Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under Medicaid, Medicare
Via Stocktwits
Topics Government
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
Via Benzinga
Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients
Via Benzinga
Topics Government
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
From Pomerantz LLP
Via GlobeNewswire
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
Via Benzinga
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Via Benzinga
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Why Novo Nordisk Stock Crumbled Again Today
Via The Motley Fool
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health
Via Benzinga
Why Novo Nordisk Stock Plummeted Today
Via The Motley Fool
Topics Stocks
Novo Nordisk A/S (NVO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
Via Stocktwits
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know
Via Benzinga
Novo Nordisk Stock Is Plummeting. Time to Panic, or Is This an Opportunity?
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.19
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 08/01/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.